Sunday, February, 12, 2012

New Adhd Drugs

Featured Article

An investigational drug for treating attention-deficit/hyperactivity disorder (ADHD) has demonstrated "significant reductions" in ADHD symptoms in new clinical trials. The drug, NRP104 (lisdexamfetamine dimesylate), is intended for use in children ages 6 to 12 and is currently under consideration for approval by the Food and Drug Administration.

Read more

More information on "New Adhd Drugs"

From Our Experts

See more SharePosts »

From Our Sources

More on ADHD »